Document is current
Any future updates will be listed below
-
Authors
He, Nianzhe
Depta, Laura
Rossetti, Cecilia https://orcid.org/0000-0001-8376-0117
Caramelle, Lucie
Cigler, Marko https://orcid.org/0000-0003-1861-7968
Bryce-Rogers, Hogan P.
Michon, Marine https://orcid.org/0009-0007-0579-3619
Rafn Dan, Oliver
Hoock, Joseph
Barbier, Julien https://orcid.org/0000-0003-2187-4973
Gillet, Daniel https://orcid.org/0000-0003-0477-3599
Forrester, Alison https://orcid.org/0000-0003-3352-9173
Winter, Georg E. https://orcid.org/0000-0001-6606-1437
Laraia, Luca https://orcid.org/0000-0001-6692-3412
- License Information
-
More Information
Article History
Received: 5 April 2023
Accepted: 16 May 2024
First Online: 21 June 2024
Competing interests
: G.E.W. is scientific founder and shareholder of Proxygen and Solgate. The Winter laboratory received funding from Pfizer. The other authors declare no competing interests.
